Promising Safety and Efficacy Results for Supraflex Cruz in HBR Subset Analysis from FIRE Trial, with 1-Month DAPT
Nov 01, 2023
Mumbai (Maharashtra) [India], November 1: SMT (Sahajanand Medical Technologies), a renowned medical device company at the forefront of innovative patient care in the cardiovascular segment, has made an announcement about the Fire Trial in HBR patients at the prestigious TCT (Transcatheter Cardiovascular Therapeutics) Conference, held in California.